興
06833
興科蓉醫藥
0.170
+0.004+2.41%Closed15:00 06/08 HKT
OPEN/PREV CLOSE0.175/0.185
TODAY RANGE0.170-0.175
VOL164.00K
MARKET CAP345.59M
52 WEEK RANGE0.151-0.278
AVG VOL (3M)296.04K
% TURNOVER0.01%
TURNOVER27.99K
P/E (TTM)8.947
% RANGE2.70%
EPS(TTM)0.019
P/E(FORWARD)--
P/B0.450
BVPS0.378
DIVIDEND0.002
P/S0.150
BETA--
DIV YIELD1.00%
FREE FLOAT MKT CAP345.59M
SHARES OUTSTANDING2.03B
NEXT EARNINGS--
FREE FLOAT2.03B
LOT SIZE4000
EX-DATE05/19/2026
News
Press Releases
Financial Reports
Profile
PUBT·05/22 08:31
Sinco Pharma names Huang Zhijian chairman of board
PUBT·04/20 11:12
Sinco Pharmaceuticals announces annual general meeting
PUBT·04/20 10:58
Sinco Pharmaceuticals releases 2025 ESG report
PUBT·04/20 10:51
Sinco Pharmaceuticals publishes 2025 annual report
Simply Wall St·01/15 00:54
Investors Don't See Light At End Of Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Tunnel
Simply Wall St·09/25/2025 06:09
Sinco Pharmaceuticals Holdings (HKG:6833) Takes On Some Risk With Its Use Of Debt
Simply Wall St·08/29/2025 22:47
Sinco Pharmaceuticals Holdings First Half 2025 Earnings: EPS: CN¥0.012 (vs CN¥0.012 in 1H 2024)
Reuters·08/27/2025 09:01
BRIEF-Sinco Pharmaceuticals Holdings Posts H1 Net Income Of RMB24.4 Mln
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.